RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/a-2593-9749
Neuroimaging and Metabolic Features of Optic Pathway Glioma in a Child with Neurofibromatosis Type 1: Low-Grade Glioma Transformation in the Left Optic Radiation
Neuroimaging und metabolische Merkmale des Sehbahnglioms bei einem Kind mit Neurofibromatose Typ 1: Niedriggradige Gliomtransformation in der linken SehbahnstrahlungAuthors
Introduction
Neurofibromatosis type 1 (NF1) is the most common single-gene genetic disorder, affecting 1/3500 children [1]. The NF-1 gene responsible for the disease is located on the length of chromosome 17 [2] [3]. NF-1 affects various organ systems, including the skin, nervous, endocrine, eye, and skeleton [2] [3]. Patients with NF-1 have a high predisposition to develop both benign and malignant tumors, including optic pathway gliomas (OPG), which are seen in 15–20% of NF-1 patients. Optic gliomas (OPG) represent 1–2% of all brain tumors, with most being benign and associated with NF-1 [1] [4] [5].
Publikationsverlauf
Eingereicht: 04. Oktober 2024
Angenommen nach Revision: 23. April 2025
Artikel online veröffentlicht:
28. Mai 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
Literatur
- 1 Listernick R, Ferner RE, Liu GT. et al. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol 2007; 61: 189-198
- 2 Quinonez J, Ruxmohan S, Paesani S. et al. Glioma-Induced Seizure in a Neurofibromatosis Type 1 Patient: A Case Report. Cureus 2021; 13: e19435
- 3 Parisi P, Persechino S, Paolino MC. et al. Four-year follow-up study in a NF1 Boy with a focal pontine hamartoma. Ital J Pediatr 2013; 39: 10
- 4 Costa ADA, Gutmann DH. Brain tumors in Neurofibromatosis type 1. Neurooncol Adv 2019; 1: vdz040
- 5 Blanchard G, Pinson S, Rouselle C. et al. Usefulness of systematic brain magnetic resonance imaging in children with neurofibromatosis type 1. Arch Pediatr 2009; 16 (12) 1527-1532
- 6 Parkhurst E, Abboy S. Optic Gliomas in Neurofibromatosis Type 1. J Pediatr Ophthalmol Strabismus 2016; 53: 334-338
- 7 Liu GT, Brodsky MC, Phillips PC. et al. Optic radiation involvement in optic path- way gliomas in neurofibromatosisl. Am J Ophthalmol 2004; 137: 407-414
- 8 Astrakas LG, Zurakowski D, Tzika AA. et al. Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors. Clin Cancer Res 2004; 10: 8220-8228
- 9 Bulik M, Jancalek R, Vanicek R. et al. Potential of MR spectroscopy for assessment of glioma grading. Clin Neurol Neurosurg 2013; 115: 146-153
- 10 Galijasevic M, Steiger R, Mangesius S. et al. Gliomas: State-of-the-Art. Cancers 2022; 14: 3197